UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

p53 in neurodegenerative diseases and brain cancers

Pharmacology & therapeutics (Oxford), 2014-04, Vol.142 (1), p.99-113

2014

Volltextzugriff (PDF)

Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation

Cell death and differentiation, 2018-05, Vol.25 (5), p.873-884

2018

Volltextzugriff (PDF)

The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson's Disease Physiopathology

Cells (Basel, Switzerland), 2020-11, Vol.9 (11), p.2495

2020

Volltextzugriff (PDF)

Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?

Cellular signalling, 2011-06, Vol.23 (6), p.963-968

2011

Volltextzugriff (PDF)

The Transcription Factor Function of Parkin: Breaking the Dogma

Frontiers in neuroscience, 2019-01, Vol.12, p.965-965

2019

Volltextzugriff (PDF)

ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1

Journal of cell science, 2013-05, Vol.126 (Pt 9), p.2124-2133

2013

Volltextzugriff (PDF)

Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models

Theranostics, 2021-01, Vol.11 (20), p.10047-10063

2021

Volltextzugriff (PDF)

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model

Parkinson's disease, 2022-11, Vol.2022, p.1-11

2022

Volltextzugriff (PDF)

China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods

Parkinson's disease, 2024-06, Vol.2024 (1), p.3561881

2024

Volltextzugriff (PDF)

Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression

Parkinson's disease, 2024-05, Vol.2024, p.8770997-11

2024

Volltextzugriff (PDF)

A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease

Parkinson's disease, 2023-09, Vol.2023, p.1-13

2023

Volltextzugriff (PDF)

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease

Parkinson's disease, 2021-12, Vol.2021, p.9919129-10

2021

Volltextzugriff (PDF)

Single-Cell Analyses Reveal Necroptosis’s Potential Role in Neuron Degeneration and Show Enhanced Neuron-Immune Cell Interaction in Parkinson’s Disease Progression

Parkinson's disease, 2023-12, Vol.2023, p.5057778-14

2023

Volltextzugriff (PDF)

Telerehabilitation: A Practical Remote Alternative for Coaching and Monitoring Physical Kinetic Therapy in Patients with Mild and Moderate Disabling Parkinson’s Disease during the COVID-19 Pandemic

Parkinson's disease, 2022-08, Vol.2022, p.1-9

2022

Volltextzugriff (PDF)

Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function

Parkinson's disease, 2023-10, Vol.2023, p.1-12

2023

Volltextzugriff (PDF)

Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson’s Disease via Bioinformatics Analysis

Parkinson's disease, 2023-04, Vol.2023, p.6755569-17

2023

Volltextzugriff (PDF)

Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo

Parkinson's disease, 2020-12, Vol.2020, p.8814236-15

2020

Volltextzugriff (PDF)

Presenilins at the crossroad of a functional interplay between PARK2/PARKIN and PINK1 to control mitophagy: Implication for neurodegenerative diseases

Autophagy, 2017-11, Vol.13 (11), p.2004-2005

2017

Volltextzugriff (PDF)

Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson’s Disease Models

Parkinson's disease, 2021-10, Vol.2021, p.1-15

2021

Volltextzugriff (PDF)

Sex Differences in the Allele Distribution of PGLYRP2 Variant rs892145 in Parkinson’s Disease

Parkinson's disease, 2023, Vol.2023, p.6502727-7

2023

Volltextzugriff (PDF)

Delirium after Deep Brain Stimulation in Parkinson’s Disease

Parkinson's disease, 2021, Vol.2021, p.8885386-9

2021

Volltextzugriff (PDF)

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis

Parkinson's disease, 2022-08, Vol.2022, p.1-10

2022

Volltextzugriff (PDF)

Upregulation of the Sarco-Endoplasmic Reticulum Calcium ATPase 1 Truncated Isoform Plays a Pathogenic Role in Alzheimer's Disease

Cells (Basel, Switzerland), 2019-11, Vol.8 (12), p.1539

2019

Volltextzugriff (PDF)

Effects of an Aquatic Physical Exercise Program on Ventilatory Parameters in People with Parkinson’s Disease

Parkinson's disease, 2022-08, Vol.2022, p.1-10

2022

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(95)
Humans
(44)
Life Sciences
(38)
Neurosciences & Neurology
(37)
Parkinson's Disease
(31)
Animals
(29)
Clinical Neurology
(29)
Neurodegenerative Diseases
(24)
Biochemistry & Molecular Biology
(22)
Movement Disorders
(22)
Proteins
(18)
Mice
(17)
Neurons And Cognition
(17)
Apoptosis
(16)
Cell Biology
(16)
Patients
(15)
Tumor Suppressor Protein P53 - Metabolism
(15)
Alzheimer's Disease
(14)
Neurosciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

p53 in neurodegenerative diseases and brain cancers

Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation

The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson's Disease Physiopathology

Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?

The Transcription Factor Function of Parkin: Breaking the Dogma

ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1

Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model

China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods

Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression

A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease

Single-Cell Analyses Reveal Necroptosis’s Potential Role in Neuron Degeneration and Show Enhanced Neuron-Immune Cell Interaction in Parkinson’s Disease Progression

Telerehabilitation: A Practical Remote Alternative for Coaching and Monitoring Physical Kinetic Therapy in Patients with Mild and Moderate Disabling Parkinson’s Disease during the COVID-19 Pandemic

Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function

Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson’s Disease via Bioinformatics Analysis

Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo

Presenilins at the crossroad of a functional interplay between PARK2/PARKIN and PINK1 to control mitophagy: Implication for neurodegenerative diseases

Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson’s Disease Models

Sex Differences in the Allele Distribution of PGLYRP2 Variant rs892145 in Parkinson’s Disease

Delirium after Deep Brain Stimulation in Parkinson’s Disease

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis

Determination of the Unilaterally Damaged Region May Depend on the Asymmetry of Carotid Blood Flow Velocity in Hemiparkinsonian Monkey: A Pilot Study

Upregulation of the Sarco-Endoplasmic Reticulum Calcium ATPase 1 Truncated Isoform Plays a Pathogenic Role in Alzheimer's Disease

Effects of an Aquatic Physical Exercise Program on Ventilatory Parameters in People with Parkinson’s Disease

Suchergebnisse filtern